U.S. Physical Therapy (USPH) Aktienübersicht
U.S. Physical Therapy, Inc. betreibt und verwaltet zusammen mit seinen Tochtergesellschaften ambulante Physiotherapie-Kliniken. Mehr Details
| Schneeflocken-Punktzahl | |
|---|---|
| Bewertung | 3/6 |
| Künftiges Wachstum | 3/6 |
| Vergangene Leistung | 1/6 |
| Finanzielle Gesundheit | 4/6 |
| Dividenden | 3/6 |
Belohnungen
Risikoanalyse
USPH Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
U.S. Physical Therapy, Inc. Wettbewerber
Preisentwicklung & Leistung
| Historische Aktienkurse | |
|---|---|
| Aktueller Aktienkurs | US$73.45 |
| 52-Wochen-Hoch | US$93.50 |
| 52-Wochen-Tief | US$58.19 |
| Beta | 1.14 |
| 1 Monat Veränderung | 18.85% |
| 3 Monate Veränderung | -3.96% |
| 1 Jahr Veränderung | -3.70% |
| 3 Jahre Veränderung | -38.61% |
| 5 Jahre Veränderung | -35.41% |
| Veränderung seit IPO | 2,939.31% |
Aktuelle Nachrichten und Updates
Analyseartikel • Jun 20
U.S. Physical Therapy (USPH) Stock Could Be 32.4% Undervalued After Profit Growth
U.S. Physical Therapy (USPH) is back in focus after recent financial disclosures showed 7.89% year-over-year revenue growth and net profit rising 115.29%, while analyst opinions and technical signals currently point in different directions for the stock. See our latest analysis for U.S. Physical Therapy. Despite the latest revenue and net profit figures, U.S. Physical Therapy’s 1-year total shareholder return declined 12.6% and the 5-year total shareholder return fell 41.7%, indicating fading...
Narrativ-Update • Jun 13
USPH: Hospital Alliances And Medicare Pricing Will Support Future Margin Upside
Analysts have lowered their price target on U.S. Physical Therapy to $90 from $103, citing somewhat lower profitability expectations and a higher projected net debt load following a mixed Q1 report. What's in the News From January 1, 2026 to March 31, 2026, U.S. Physical Therapy reported no share repurchases, with 0 shares bought for US$0 million under its existing buyback program (Key Developments).Narrativ-Update • May 30
USPH: Hospital Alliances And Medicare Pricing Will Drive Future Margin Recovery
Analysts have trimmed their blended price target on U.S. Physical Therapy from about $107 to roughly $94, reflecting lower P/E assumptions and somewhat softer profitability expectations, along with higher net debt. They also note potential margin improvement supported by hospital alliances and improved Medicare rates.Seeking Alpha • May 22
U.S. Physical Therapy: The Valuation Reset Changes The Story (Rating Upgrade)
Summary U.S. Physical Therapy, Inc. has seen valuation multiples compress significantly despite continued revenue growth and new strategic initiatives. U.S. Physical Therapy reported Q1 2026 revenue of $198.3M (+7.9% YoY) but missed EPS expectations due to higher costs from acquisitions and clinic startups. Management is pursuing hospital partnerships and shifting toward private insurance, aiming to boost clinic utilization and reduce reliance on Medicare/Medicaid. I now rate U.S. Physical Therapy as hold, reflecting improved risk/reward at current valuation but acknowledging persistent structural challenges and margin pressures. Read the full article on Seeking AlphaRecent updates
Analyseartikel • Jun 20
U.S. Physical Therapy (USPH) Stock Could Be 32.4% Undervalued After Profit Growth
U.S. Physical Therapy (USPH) is back in focus after recent financial disclosures showed 7.89% year-over-year revenue growth and net profit rising 115.29%, while analyst opinions and technical signals currently point in different directions for the stock. See our latest analysis for U.S. Physical Therapy. Despite the latest revenue and net profit figures, U.S. Physical Therapy’s 1-year total shareholder return declined 12.6% and the 5-year total shareholder return fell 41.7%, indicating fading...Narrativ-Update • Jun 13
USPH: Hospital Alliances And Medicare Pricing Will Support Future Margin Upside
Analysts have lowered their price target on U.S. Physical Therapy to $90 from $103, citing somewhat lower profitability expectations and a higher projected net debt load following a mixed Q1 report. What's in the News From January 1, 2026 to March 31, 2026, U.S. Physical Therapy reported no share repurchases, with 0 shares bought for US$0 million under its existing buyback program (Key Developments).Narrativ-Update • May 30
USPH: Hospital Alliances And Medicare Pricing Will Drive Future Margin Recovery
Analysts have trimmed their blended price target on U.S. Physical Therapy from about $107 to roughly $94, reflecting lower P/E assumptions and somewhat softer profitability expectations, along with higher net debt. They also note potential margin improvement supported by hospital alliances and improved Medicare rates.Seeking Alpha • May 22
U.S. Physical Therapy: The Valuation Reset Changes The Story (Rating Upgrade)
Summary U.S. Physical Therapy, Inc. has seen valuation multiples compress significantly despite continued revenue growth and new strategic initiatives. U.S. Physical Therapy reported Q1 2026 revenue of $198.3M (+7.9% YoY) but missed EPS expectations due to higher costs from acquisitions and clinic startups. Management is pursuing hospital partnerships and shifting toward private insurance, aiming to boost clinic utilization and reduce reliance on Medicare/Medicaid. I now rate U.S. Physical Therapy as hold, reflecting improved risk/reward at current valuation but acknowledging persistent structural challenges and margin pressures. Read the full article on Seeking AlphaAnalyseartikel • Sep 12
These 4 Measures Indicate That U.S. Physical Therapy (NYSE:USPH) Is Using Debt Reasonably Well
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...Analyseartikel • Aug 02
Pinning Down U.S. Physical Therapy, Inc.'s (NYSE:USPH) P/E Is Difficult Right Now
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 17x, you may...Analyseartikel • Jul 11
U.S. Physical Therapy (NYSE:USPH) Is Reinvesting At Lower Rates Of Return
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a...Analyseartikel • Jun 10
Here's Why U.S. Physical Therapy (NYSE:USPH) Can Manage Its Debt Responsibly
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...Analyseartikel • May 14
Here's Why It's Unlikely That U.S. Physical Therapy, Inc.'s (NYSE:USPH) CEO Will See A Pay Rise This Year
Key Insights U.S. Physical Therapy's Annual General Meeting to take place on 20th of May CEO Chris Reading's total...Analyseartikel • Mar 24
Should You Think About Buying U.S. Physical Therapy, Inc. (NYSE:USPH) Now?
U.S. Physical Therapy, Inc. ( NYSE:USPH ), might not be a large cap stock, but it received a lot of attention from a...Analyseartikel • Mar 01
U.S. Physical Therapy, Inc. Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next
Last week, you might have seen that U.S. Physical Therapy, Inc. ( NYSE:USPH ) released its yearly result to the market...Analyseartikel • Feb 28
U.S. Physical Therapy (NYSE:USPH) Seems To Use Debt Quite Sensibly
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...Analyseartikel • Jan 03
Capital Allocation Trends At U.S. Physical Therapy (NYSE:USPH) Aren't Ideal
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. In a perfect...Analyseartikel • Nov 09
Shareholders Should Be Pleased With U.S. Physical Therapy, Inc.'s (NYSE:USPH) Price
When close to half the companies in the Healthcare industry in the United States have price-to-sales ratios (or "P/S...
Neues Narrativ • Sep 14
Tactical Contract Renegotiations And Innovative Recruitment Tactics Propel Revenue Growth And Margin Expansion
Innovations in recruitment and operational efficiencies are set to bolster net margins despite a tight labor market and high costs.Analyseartikel • Aug 07
U.S. Physical Therapy (NYSE:USPH) Might Be Having Difficulty Using Its Capital Effectively
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'll...Analyseartikel • Jul 17
U.S. Physical Therapy (NYSE:USPH) Has A Rock Solid Balance Sheet
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Analyseartikel • Jun 04
U.S. Physical Therapy, Inc.'s (NYSE:USPH) Business Is Trailing The Industry But Its Shares Aren't
When you see that almost half of the companies in the Healthcare industry in the United States have price-to-sales...Analyseartikel • May 21
There May Be Reason For Hope In U.S. Physical Therapy's (NYSE:USPH) Disappointing Earnings
The market for U.S. Physical Therapy, Inc.'s ( NYSE:USPH ) shares didn't move much after it posted weak earnings...Analyseartikel • May 11
U.S. Physical Therapy (NYSE:USPH) Is Due To Pay A Dividend Of $0.44
The board of U.S. Physical Therapy, Inc. ( NYSE:USPH ) has announced that it will pay a dividend of $0.44 per share on...Analyseartikel • May 05
Returns On Capital Signal Tricky Times Ahead For U.S. Physical Therapy (NYSE:USPH)
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Analyseartikel • Apr 21
A Look At The Fair Value Of U.S. Physical Therapy, Inc. (NYSE:USPH)
Key Insights Using the 2 Stage Free Cash Flow to Equity, U.S. Physical Therapy fair value estimate is US$113 U.S...Analyseartikel • Apr 07
Is Now The Time To Look At Buying U.S. Physical Therapy, Inc. (NYSE:USPH)?
While U.S. Physical Therapy, Inc. ( NYSE:USPH ) might not have the largest market cap around , it saw a decent share...Analyseartikel • Mar 04
U.S. Physical Therapy, Inc.'s (NYSE:USPH) Shareholders Might Be Looking For Exit
When you see that almost half of the companies in the Healthcare industry in the United States have price-to-sales...Analyseartikel • Dec 23
The Returns On Capital At U.S. Physical Therapy (NYSE:USPH) Don't Inspire Confidence
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a...Analyseartikel • Dec 07
Why U.S. Physical Therapy, Inc. (NYSE:USPH) Could Be Worth Watching
While U.S. Physical Therapy, Inc. ( NYSE:USPH ) might not be the most widely known stock at the moment, it saw a...Aktionärsrenditen
| USPH | US Healthcare | US Markt | |
|---|---|---|---|
| 7D | 1.5% | 0.3% | -0.4% |
| 1Y | -3.7% | 29.8% | 18.4% |
Rendite im Vergleich zur Industrie: USPH unter dem Niveau der Branche US Healthcare , die im vergangenen Jahr eine Rendite von 29.8% erzielte.
Rendite vs. Markt: USPH hinter dem Markt US zurück, der im vergangenen Jahr eine Rendite von 18.4 erzielte.
Preisvolatilität
| USPH volatility | |
|---|---|
| USPH Average Weekly Movement | 7.8% |
| Healthcare Industry Average Movement | 7.3% |
| Market Average Movement | 7.3% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.2% |
Stabiler Aktienkurs: USPH hatte in den letzten 3 Monaten im Vergleich zum US -Markt keine signifikante Preisvolatilität.
Volatilität im Zeitverlauf: USPHDie wöchentliche Volatilität (8%) ist im vergangenen Jahr stabil geblieben.
Über das Unternehmen
| Gegründet | Mitarbeiter | CEO | Website |
|---|---|---|---|
| 1990 | 6,374 | Chris Reading | www.usph.com |
U.S. Physical Therapy, Inc. betreibt und verwaltet zusammen mit seinen Tochtergesellschaften ambulante Physiotherapie-Kliniken. Das Unternehmen ist in zwei Segmenten tätig: Physical Therapy Operations und Industrial Injury Prevention Services. Das Unternehmen bietet prä- und postoperative Versorgung und Behandlung von orthopädischen Erkrankungen, Sportverletzungen, präventive Versorgung, Rehabilitation von verletzten Arbeitnehmern und neurologischen Verletzungen.
U.S. Physical Therapy, Inc.'s Grundlagenzusammenfassung
| USPH grundlegende Statistiken | |
|---|---|
| Marktanteil | US$1.07b |
| Gewinn(TTM) | US$7.67m |
| Umsatz(TTM) | US$787.69m |
145.8x
Kurs-Gewinn-Verhältnis 1.4x
Kurs-Umsatz-VerhältnisIst USPH zu teuer?
Siehe Fair Value und BewertungsanalyseErträge & Einnahmen
| USPH Gewinn- und Verlustrechnung (TTM) | |
|---|---|
| Einnahmen | US$787.69m |
| Kosten der Einnahmen | US$615.17m |
| Bruttogewinn | US$172.52m |
| Sonstige Ausgaben | US$164.85m |
| Gewinn | US$7.67m |
Zuletzt gemeldete Gewinne
Mar 31, 2026
Datum des nächsten Gewinnberichts
Aug 06, 2026
| Gewinn per Aktie (EPS) | 0.50 |
| Bruttomarge | 21.90% |
| Nettogewinnspanne | 0.97% |
| Schulden/Eigenkapital-Verhältnis | 26.2% |
Wie hat sich USPH auf lange Sicht entwickelt?
Historische Performance und VergleicheDividenden
2.5%
Aktuelle Dividendenrendite358%
AusschüttungsquoteUnternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/07/09 22:45 |
| Aktienkurs zum Tagesende | 2026/07/09 00:00 |
| Gewinne | 2026/03/31 |
| Jährliche Einnahmen | 2025/12/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Details des Analysemodells, das zur Erstellung dieses Berichts verwendet wurde, sind auf unserer GitHub-Seite verfügbar. Außerdem haben wir Leitfäden zur Nutzung unserer Berichte und Tutorials auf YouTube.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
U.S. Physical Therapy, Inc. wird von 15 Analysten beobachtet. 7 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Michael Petusky | Barrington Research Associates, Inc. |
| Joanna Sylvia Gajuk | BofA Global Research |
| Joseph France | Cantor Fitzgerald & Co. |